A psychosocial approach to erectile dysfunction: position statements from the European Society of Sexual Medicine (ESSM)

M Dewitte, C Bettocchi, J Carvalho, G Corona… - Sexual …, 2021 - academic.oup.com
Introduction Although erectile dysfunction (ED) involves an interaction between
physiological and psychological pathways, the psychosocial aspects of ED have received …

Novel emerging therapies for erectile dysfunction

S Kim, MC Cho, SY Cho, H Chung… - The world journal of …, 2020 - pmc.ncbi.nlm.nih.gov
Currently, several treatments exist for the improvement of erectile dysfunction (ED). These
include medical therapies such as phosphodiesterase type 5 inhibitors (PDE5-Is), invasive …

Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis

I Mykoniatis, N Pyrgidis, I Sokolakis… - JAMA network …, 2021 - jamanetwork.com
Importance Combining 2 first-line treatments for erectile dysfunction (ED) or initiating other
modalities in addition to a first-line therapy may produce beneficial outcomes. Objective To …

Observation of Two Resonances in the Systems and Precise Measurement of and Properties

R Aaij, C Abellán Beteta, B Adeva, M Adinolfi… - Physical review …, 2019 - APS
The first observation of two structures consistent with resonances in the final states Λ b 0 π-
and Λ b 0 π+ is reported using samples of pp collision data collected by the LHCb …

A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical …

MK Haahr, CH Jensen, NM Toyserkani, DC Andersen… - Urology, 2018 - Elsevier
Objective To explore safety in adipose-derived regenerative cells (ADRC) therapy, treating
erectile dysfunction (ED). Methods Twenty-one patients with ED after radical prostatectomy …

The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of …

G Corona, D Cucinotta, G Di Lorenzo, A Ferlin… - Journal of …, 2023 - Springer
Purpose Erectile dysfunction (ED) is one of the most prevalent male sexual dysfunctions. ED
has been in the past mistakenly considered a purely psycho-sexological symptom by …

Facing counterfeit medications in sexual medicine. A systematic scoping review on social strategies and technological solutions

A Sansone, B Cuzin, EA Jannini - Sexual Medicine, 2021 - academic.oup.com
Introduction The counterfeit phenomenon is a largely under-reported issue, with potentially
large burden for healthcare. The market for counterfeit drugs used in sexual medicine, most …

Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis

CR Madeira, FS Tonin, MM Fachi, HH Borba… - World Journal of …, 2021 - Springer
Purpose To quantitatively assess the benefit–risk ratio on the efficacy and safety of all
phosphodiesterase type 5 inhibitors (PDE5i) in men with erectile dysfunction. Methods A …

A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation

V Mirone, L Napolitano… - Archivio Italiano di …, 2021 - pagepressjournals.org
Objective: To assess the efficacy of the combination of Tadalafil 5 mg and nutritional
supplements composed by Panax ginseng, Moringa Oleifera and Rutin on erectile function …

Patient out-of-pocket costs for guideline-recommended treatments for erectile dysfunction: a medicare cost modeling analysis

V Nguyen, AM McGovern, S Rojanasarot… - International Journal of …, 2025 - nature.com
Patient out-of-pocket (OOP) cost represents an access barrier to erectile dysfunction (ED)
treatment. We determined OOP cost for men with ED covered by Fee-for-Service Medicare …